Abstract
Bovine pulmonary artery smooth muscle tissue possesses the tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) as revealed by immunoblot studies of the cytosolic fraction with polyclonal TIMP-1 antibody. In this report, we described the purification and partial characterization of the inhibitor from the cytosolic fraction of the smooth muscle. This inhibitor was purified by a series of anion-exchange, gel filtration and affinity chromatographic procedure. The purified inhibitor showed an apparent molecular mass of 30 kDa in SDS-PAGE. Amino terminal sequence analysis for the first 22 amino acids of the purified inhibitor was also found to be identical to bovine TIMP-1. This glycosylated inhibitor was found to be active against matrix metallorpoteinase-9 (MMP-9, gelatinase B), the ambient matrix metalloproteinase in the pulmonary smooth muscle. The purified TIMP-1 was also found to be sensitive to pure rabbit and human fibroblast collagenase and type IV collagenase. In contrast, it had minimum inhibitory activity against bacterial collagenase. It was also found to be inactive against the serine proteases trypsin and plasmin. The inhibitor was heat and acid resistant and it had the sensitivity to trypsin degradation and reduction-alkylation.
Similar content being viewed by others
References
Chakraborti T, Das S, Mandal M, Mandal A, Chakraborti S: Role of Ca2+ dependent matrix metalloprotease-2 in stimulating Ca2+ ATPase activity under peroxynitrite treatment in pulmonary vascular smooth muscle plasma membrane. IUBMB Life 53: 167-173, 2002
Mandal M, Chakraborti T, Das S, Mandal A, Chakraborti S: Matrix metalloprotease-2 mediated activation of Ca2+ ATPase by superoxide radical (O2·−) in plasma membrane of bovine pulmonary vascular smooth muscle. Indian J Biochem Biophys 39: 390-396, 2002
Das S, Chakraborti T, Mandal M, Mandal A, Chakraborti S: Role of membrane-associated Ca2+ dependent matrix metalloprotease-2 in the oxidant activation of Ca2+ ATPase by tertiary butylhydroperoxide. Mol Cell Biochem 237: 85-93, 2002
Nagase H, Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 274: 21491-21504, 1999
Gay S, Miller J: In: S. Gay, J. Miller (eds). Collagen in the Physiology and Pathology of Connective Tissue. Fisher, Stuttgart, 1978, pp 88-110
Stemlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001
Khokha R, Denhardt DT: Matrix metalloproteinases and tissue inhibitor of metalloproteinases: A review of their role in tumorigenesis and tissue invasion. Invasion Metastasis 9: 391-405, 1989
Woessner JF Jr: Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann NY Acad Sci USA 878: 388-403, 1999
Wooley DE: In: R.E. Piez, A.H. Reddi (eds). Extracellular Matrix Biochemistry. Elsevier, New York, 1984, pp 119-159
Eisenstein R, Sorgente N, Soble LW, Miller A, Kuettner KE: The resistance of certain tissues to invasion: Penetrability of explanted tissues by vascularized mesenchyme. Am J Pathol 73: 765-74, 1973
Travis J, Salvesen GS: Human plasma proteinase inhibitors. Annu Rev Biochem 52: 655-709, 1983
Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4: 197-250, 1993
Cawston TE, Galloway WA, Mercer E, Murphy G, Reynolds JJ: Purification of rabbit bone inhibitor of collagenase. Biochem J 195: 159-165, 1981
Murphy G, Cawston TE, Reynolds JJ: An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J 195: 167-170, 1981
Bunning RA, Murphy G, Kumar S, Phillips P, Reynolds JJ: Metalloproteinase inhibitors from bovine cartilage and body fluids. Eur J Biochem 139: 75-80, 1984
Welgus HG, Stricklin GP: Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem 258: 12259-12264, 1983
Stricklin GP, Welgus HG: Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem 258: 12252-12258, 1983
Herron GS, Banda MJ, dark EJ, Gavrilovic J, Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261: 2814-2818, 1986
DeClerck YA: Purification and characterization of a collagenase inhibitor produced by bovine vascular smooth muscle cells. Arch Biochem Biophys 265: 28-37, 1988
Gavrilovic J, Hembry RM, Reynolds JJ, Murphy G: Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells. J Cell Sci 87: 357-362, 1987
Cawston TE, Murphy G, Mercer E, Galloway WA, Hazleman BL, Reynolds JJ: The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J 211: 313-318, 1983
Roswit WT, McCourt DW, Partridge NC, Jeffrey JJ: Purification and sequence analysis of two rat tissue inhibitors of metalloproteinases. Arch Biochem Biophys 292: 402-410, 1992
Edwards DR, Waterhouse P, Holman ML, Denhardt DT: A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. Nucleic Acids Res 14: 8863-8878, 1986
Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G, Reynolds JJ: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318: 66-69, 1985
Carmichael DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG, Stricklin GP: Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci USA 83: 2407-2411, 1986
Burke JM, Balian G, Ross R, Bomstein P: Synthesis of types I and III procollagen and collagen by monkey aortic smooth muscle cells in vitro. Biochemistry 16: 3243-3249, 1977
Kamp HH, Wirtz KW: Phosphatidylcholine exchange protein from beef liver. Meth Enzymol 32: 140-146, 1974
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76: 4350-4354, 1979
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227: 680-685, 1970
Wray W, Boulikas T, Wray VP and Hancock R: Silver staining of proteins in polyacylamide gels. Anal Biochem 118: 197-203, 1981
Billings PC, Habres JM, Liao DC, Tuttle SW: Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res 51: 5539-5543, 1991
Welgus HG, Stricklin GP, Eisen AZ, Bauer EA, Cooney RV, Jeffrey JJ: A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem 254: 1938-1943, 1979
DeClerck YA, Yean T-D, Ratzkin BJ, Lu HS, Langley KE: Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264: 17445-17453, 1989
Laug WE: Secretion of plasminogen activators by cultured bovine endothelial cells: Partial purification, characterization and evidence for multiple forms. Thromb Haemost 45: 219-224, 1981
Matsudaira P: Sequence from picomole quantities of proteins electro-blotted onto polyvinylidene difluoride membranes. J Biol Chem 262: 10035-10038, 1987
David WW: In: Biostatistics: A Foundation for Analysis in Health Science. Wiley, New York, 1978, p 219
Cawston TE, Mercer E, de Silva M, Hazleman BL: Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arth Rheum 27: 285-290, 1984
Murphy G, Willenbrock F: Tissue inhibitors of matrix metalloendopeptidases. Meth Enzymol 248: 496-510, 1995
Olson MW, Gervasi DC, Mobashery S, Fridman F: Kinetic analysis of the binding of human matrix metalloproteinase-2 and-9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem 272: 29975-29983, 1997
Brew K, Dinakarpandian D, Nagase H: Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477: 267-283, 2000
Liotta LA, Rao CN, Barsky SH: Tumor invasion and the extracellular matrix. Lab Invest 49: 636-649, 1983
Lijnen HR: Extracellular proteolysis in the development and progression of atherosclerosis. Biochem Soc Trans 30: 163-167, 2002
Romanic AM, Harrison SM, Bao W, Bums-Kurtis CL, Pickering S, Gu J, Grau E, Mao J, Sathe GM, Ohistein EH, Yue TL: Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiovasc Res 54: 549-58, 2002
Silence J, Collen D, Lijnen HR: Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 90: 897-903, 2002
Timms PM, Wright A, Maxwell P, Campbell S, Dawnay AB, Srikanthan V: Plasma tissue inhibitor of metalloproteinase-1 levels are elevated in essential hypertension and related to left ventricular hypertrophy. Am J Hypertens 15: 269-272, 2002
Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ: Matrix metalloproteinases in human melanoma. J Invest Dermatol 115: 337-344, 2000
Mignatti P, Robbins E, Rifkin DB: Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 47: 487-498, 1986
Brand K: Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs). Curr Gene Ther 2: 255-271, 2002
Lamfers ML, Grimbergen JM, Aalders MC, Havenga MJ, de Vries MR, Huisman LG, Van Hinsbergh VW, Quax PH: Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1. Circ Res 91: 945-952, 2002
Lijnen HR: Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 86: 324-333, 2001
Forough R, Koyama N, Hasenstab D, Lea H, Clowes M, Nikkari ST, Clowes AW: Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res 79: 812-820, 1996
Kanda S, Kuzuya M, Ramos MA, Koike T, Yoshino K, Ikeda S, Iguchi A: Matrix metalloproteinase and alphavbeta3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice. Arterioscler Thromb Vase Biol 20: 998-1005, 2000
Ohbayashi H: Matrix metalloproteinases in lung diseases. Curr Prot Peptide Sci 3: 409-421, 2002
Weir EK, Archer SL, Rubin LJ: In: J.T. Willerson, J.N. Cohn (eds). Cardiovascular Medicine. Churchill Livingstone, New York, 1995, pp 1495-1523
Stroud JD, Baicu CF, Bames MA, Spinale FG, Cox MJ: Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment. Am J Physiol 282: H2324-H2335, 2002
Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75: 539-545, 1994
Zempo N, Koyama N, Kenagy RD, Lea HJ, Clowes AW: Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vase Biol 16: 28-33, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mandal, M., Das, S., Chakraborti, T. et al. Identification, purification and partial characterization of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in bovine pulmonary artery smooth muscle. Mol Cell Biochem 254, 145–155 (2003). https://doi.org/10.1023/A:1027312913250
Issue Date:
DOI: https://doi.org/10.1023/A:1027312913250